BioForce Nanosciences (BFNH) Stock Price, News & Analysis

Company Overview

BioForce Nanosciences, Inc. (OTCMKTS:BFNH) is a U.S.-based developer and manufacturer of nanoscale tools and materials for research and industrial applications. Founded in 1998 as a university spin-off in Ames, Iowa, the company specializes in high-precision atomic force microscopy (AFM) probes and biolistic (“gene gun”) particle delivery systems. Its products are designed to meet the rigorous demands of academic, government and commercial research environments.

The company’s flagship product line includes silicon nitride and diamond-coated AFM probes engineered for high aspect-ratio imaging, enhanced durability and consistent performance. BioForce also offers the Nano eNabler®, a benchtop biolistic transfection device that enables researchers in life sciences, agriculture, cosmetics and biofuels to deliver DNA, RNA, proteins and other biomolecules into cells with micrometer-scale precision. In addition to catalog offerings, BioForce provides custom design services, small-scale manufacturing and technical support for specialized nanoscale applications.

BioForce Nanosciences serves a global customer base, distributing its products throughout North America, Europe and Asia via direct sales and authorized distributors. Its probes and delivery systems are employed in university laboratories, government research centers and leading pharmaceutical and biotech companies. The firm’s commitment to quality and innovation has made its AFM tips and biolistic instruments well regarded among nanoscale research communities worldwide.

Guided by a leadership team of seasoned nanotechnology and biotechnology professionals, BioForce continues to expand its product portfolio and advance next-generation research tools. The company has collaborated on grants and joint development projects with academic institutions and industrial partners, underscoring its focus on both scientific excellence and practical commercialization. With a strategic emphasis on innovation, BioForce Nanosciences aims to support breakthroughs in material science, molecular biology and related fields.

Key Stats

• Today's Range: $0.40 to $0.51
• 50-Day Range: $0.41 to $0.55
• 52-Week Range: $0.16 to $1.44
• Volume: 2,099 shs
• Average Volume: 1,929 shs
• Market Capitalization: $13.48 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

BFNH Stock Analysis - Frequently Asked Questions

How have BFNH shares performed this year?

BioForce Nanosciences' stock was trading at $0.3415 on January 1st, 2025. Since then, BFNH shares have increased by 17.7% and is now trading at $0.4021.

How were BioForce Nanosciences' earnings last quarter?

BioForce Nanosciences Holdings Inc. (OTCMKTS:BFNH) posted its quarterly earnings results on Tuesday, May, 13th. The company reported ($0.03) earnings per share for the quarter.

How do I buy shares of BioForce Nanosciences?

Shares of BFNH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of BioForce Nanosciences own?

Based on aggregate information from My MarketBeat watchlists, some other companies that BioForce Nanosciences investors own include Nano One Materials (NANO) and Charlotte's Web (CWBHF).

Company Calendar

• Last Earnings: 5/13/2025
• Today: 7/14/2025
• Next Earnings (Estimated): 8/05/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: MED - BIOMED/GENE
• Sub-Industry: Measuring And Control Equipment
• Current Symbol: OTCMKTS:BFNH
• CIK: 1310488
• Web: www.bioforceeclipse.com
• Phone: (757) 306-6090
• Fax: 757-306-6092
• Employees: 2
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): ($0.04)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$490 thousand
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: -30,513.47%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.05
• Quick Ratio: 0.05

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($0.07) per share
• Price / Book: -5.74

Miscellaneous

• Outstanding Shares: 33,522,000
• Free Float: 20,267,000
• Market Cap: $13.48 million
• Optionable: Not Optionable
• Beta: -1.31